`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`Inter Partes Review No.: IPR2021-00881
`
`
`U.S. Patent No. 9,254,338 B2
`Filed: July 12, 2013
`Issued: February 9, 2016
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`Petitioner’s Amended Mandatory Notices
`
`
`
`Pursuant to the Board’s September 22, 2021 Order (Paper 14), Mylan
`
`Pharmaceuticals Inc. (“Petitioner”) submits its amended mandatory notices.
`
` REAL PARTIES-IN-INTEREST (37 C.F.R. § 42.8(b)(1)) (AMENDED).
`
`Viatris Inc. and Mylan Inc. are parent companies of Petitioner Mylan
`
`Pharmaceuticals Inc.
`
` Accordingly, Viatris Inc., Mylan Inc., and Mylan
`
`Pharmaceuticals Inc. are identified as real parties-in-interest to the current Petition.
`
`Momenta Pharmaceuticals, Inc. and Janssen Research & Development LLC are
`
`wholly-owned
`
`subsidiaries of
`
`Johnson &
`
`Johnson, a publicly held
`
`company. Momenta Pharmaceuticals, Inc., Janssen Research & Development LLC,
`
`and Johnson & Johnson are also real parties-in-interest to the current Petition. No
`
`other parties exercised or could have exercised control over this Petition; no other
`
`parties funded, directed and controlled this Petition. See Trial Practice Guide, 77
`
`Fed. Reg. 48759-60 (Aug. 14, 2021).
`
` RELATED MATTERS (37 C.F.R. § 42.8(b)(2)) (AMENDED).
`
`Petitioner identifies Mylan Pharms. Inc. v. Regeneron Pharms., Inc., No.
`
`IPR2021-00880 (P.T.A.B.), filed concurrently herewith. To the best of Petitioner’s
`
`knowledge, there are no other judicial or administrative matters that would affect, or
`
`be affected by, a decision in this proceeding; nonetheless, out of an abundance of
`
`caution, Petitioner further identifies Chengdu Kanghong Biotechnology Co. v.
`
`Regeneron Pharms., Inc., No. PGR2021-00035 (P.T.A.B.).
`
`1
`
`
`
`U.S. Patent Nos. 9,669,069 B2, 10,130,681 B2, 10,857,205 B2, 10,828,345
`
`B2, and 10,888,601; and U.S. Patent Application Nos. 17/072,417, 17/112,063,
`
`17/112,404, 17/350,958, and 17/352,892 claim the benefit of the ’338 patent filing
`
`date.
`
` LEAD AND BACK-UP COUNSEL AND SERVICE INFORMATION (37
`C.F.R. § 42.8(b)(3)-(4)).
`
`Petitioner identifies its lead and backup counsel below. A Power of Attorney
`
`is filed concurrently herewith under 37 C.F.R. § 42.10(b).
`
`Lead
`
`Back-Up
`
`Paul J. Molino (Reg. No. 45,350)
`paul@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 222-6300
`Facsimile: (312) 843-6260
`
`Petitioner consents to email service at:
`MYL_REG_IPR@rmmslegal.com
`
`
`William A. Rakoczy
`(admitted pro hac vice)
`wrakoczy@rmmslegal.com
`
`Heinz J. Salmen
`(admitted pro hac vice)
`hsalmen@rmmslegal.com
`
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 222-5127
`Facsimile: (312) 843-6260
`
`
`
`
`2
`
`
`
`Please direct all correspondence to lead and back-up counsel at the contact
`
`information above.
`
` Petitioner also consents
`
`to service by email at:
`
`MYL_REG_IPR@rmmslegal.com.
`
`Dated: October 1, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Paul J. Molino/
`Paul J. Molino
`Registration No. 45,350
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone:
`(312) 222-6300
`Facsimile:
`(312) 843-6260
`paul@rmmslegal.com
`
`
`Counsel for Petitioner
`
`
`
`
`
`
`
`3
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of the foregoing
`
`Petitioner’s Amended Mandatory Notices was served on October 1, 2021, via
`
`electronic mail by agreement of the parties, to the following counsel for record of
`
`Patent Owners:
`
`Deborah E. Fishman (Reg. No. 48,621)
`ARNOLD & PORTER KAYE SCHOLER LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deborah.Fishman@arnoldporter.com
`RegeneronEyleaIPRs@arnoldporter.com
`
`Matthew M. Wilk
`Arnold & Porter Kaye Scholer LLP
`250 West 55th Street
`New York, New York 10019-9710
`Telephone: 212.836.8000
`Fax: 212.836.8689
`Matthew.Wilk@arnoldporter.com
`
`Dated: October 1, 2021
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines
`Rebecca Neubauer
`ARNOLD & PORTER KAYE SCHOLER LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Rebecca.Neubauer@arnoldporter.com
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Paul J. Molino/
`
`
`
`
`
`
`
`